<code id='802BD272B5'></code><style id='802BD272B5'></style>
    • <acronym id='802BD272B5'></acronym>
      <center id='802BD272B5'><center id='802BD272B5'><tfoot id='802BD272B5'></tfoot></center><abbr id='802BD272B5'><dir id='802BD272B5'><tfoot id='802BD272B5'></tfoot><noframes id='802BD272B5'>

    • <optgroup id='802BD272B5'><strike id='802BD272B5'><sup id='802BD272B5'></sup></strike><code id='802BD272B5'></code></optgroup>
        1. <b id='802BD272B5'><label id='802BD272B5'><select id='802BD272B5'><dt id='802BD272B5'><span id='802BD272B5'></span></dt></select></label></b><u id='802BD272B5'></u>
          <i id='802BD272B5'><strike id='802BD272B5'><tt id='802BD272B5'><pre id='802BD272B5'></pre></tt></strike></i>

          fashion

          fashion

          author:knowledge    Page View:7
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          What the cancer research community can learn from the Covid response
          What the cancer research community can learn from the Covid response

          TinaReed,PaulKluetz,JohnOyler,andSolangePetersspeakattheMilkenInstituteFutureofHealthSummit.Screenca

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

          InhonorofJPMWeek,you’rereadingaspecialeditionofourbiotechnewsletter,TheReadout.Tostayontopofthelates